0.6498USD+2.74%Mkt Cap: 25.67M USDP/E: —Last update: 2026-06-01
Vistagen Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development and commercialization of therapies for neuropsychiatric and neurological disorders. The company's product pipeline inclu…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap25.67M USD
Enterprise Value-35.38M USD
Revenue (TTM)789.00K USD
Gross Profit789.00K USD
Net Income (TTM)-51.42M USD
Revenue/Share0.0220 USD
Last Price0.6498 USD
Fiscal Year EndMar 2025
MR QuarterDec 2025
Employees59
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-0.65
PEG—
EV/EBITDA0.51
EV/Revenue-44.84
P/S31.64
P/B0.49
EPS (TTM)-1.90
EPS (Forward)-0.98
52W Range
0.43005% of range5.140
52W High5.140 USD
52W Low0.4300 USD
Profitability
Gross Margin100.00%
Oper. Margin-6450.83%
EBITDA Margin0.00%
Profit Margin-10579.84%
ROE-73.05%
ROA-60.96%
Growth
Revenue Growth29.50%
Earnings Growth—
Cash Flow & Leverage
Operating CF-42.10M USD
CapEx (TTM)191.00K USD
FCF Margin-4583.90%
FCF Yield-140.89%
Net Debt-60.34M USD
Net Debt/EBITDA0.87
Balance Sheet
Debt/Equity0.02
Current Ratio4.67
Quick Ratio4.57
Book Value/Sh1.285 USD
Cash/Share1.559 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:30
Split DateJun 7, 2023
Analyst Consensus
Rating—
Target (Mean)0.9667 USD
Target Range0.9000 USD – 1.000 USD
# Analysts3
Ownership
Shares Out.39.62M
Float34.38M
Insiders0.27%
Institutions42.26%
Short Interest
Short Ratio1.6d
Short % Float6.47%
Short % Out.4.54%
Shares Short1.80M
Short (prev mo.)1.71M
Technical
SMA 500.6054 (+7.3%)
SMA 2002.027 (-67.9%)
Beta0.30
S&P 52W Chg27.70%
Avg Vol (30d)969.53K
Avg Vol (10d)527.94K
Technical Indicators
RSI (14)52.0
MACD0.0084
MACD Signal0.0088
MACD Hist.-0.0004
BB Upper0.6701 USD
BB Middle0.6288 USD
BB Lower0.5875 USD
BB Width13.13%
ATR (14)0.0460 USD
Vol Ratio (20d)0.71x